本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
SHANGHAI, Feb. 3, 2026 /PRNewswire/ -- WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service agreement with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) for an innovative trispecific T-cell Engager (TCE) for the treatment of B-cell mediated autoimmune diseases. Under the agreement, Vertex will have exclusive global rights to develop and commercialize an innovative trispecific TCE at the preclinical stage designed for the treatment of B-cell mediated autoimmune diseases. WuXi Biologics will receive an upfront payment and is eligible to receive development, regulatory, and sales milestone payments, as well as royalty payments. In addition, WuXi Biologics will provide Vertex with contract research and development services on novel next-generation TCEs. Dr. Chris Chen, CEO of WuXi Biologics, commented, "We are delighted to support Vertex's efforts to bring forward transformative medicines for serious diseases through the study of this TCE, discovered using our state-of-the-art integrated platforms. This collaboration underscores WuXi Biologics' recognition as an industry leader in discovery service solutions and further validates our unique CRDMO model, which enables global partners to develop next-generation modalities." "At Vertex, we are committed to advancing transformative therapies for people with serious diseases," said Dr. Mark Bunnage, Chief Scientific Officer at Vertex. "This agreement with WuXi Biologics gives us another important tool to accelerate our efforts to advance new medicines and we're excited to explore the potential of this promising molecule." About WuXi Biologics WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide. With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing. WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives green technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while consistently achieving excellence in Environment, Social and Governance (ESG). Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain. For more information about WuXi Biologics, please visit: www.wuxibiologics.com.
Dali Jia Ma Prints and Fengxian Printmaking Exhibited at CHANDO Future Beauty Innovation Hub SHANGHAI, Feb. 3, 2026 /PRNewswire/ -- On January 29, 2026, the exhibition Tracing Beauty in Motion — A Printmaking Exchange between Dali Jia Ma Woodblock Prints of Yunnan and Fengxian Printmaking of Shanghai opened to the public at Oriental Beauty Valley CHANDO Future Beauty Innovation Hub. The exhibition is presented in coordination with the Shanghai Municipal Office for Cultural and Creative Industries and the Cooperation and Exchange Office of Shanghai Municipal People's Government, with institutional support from the Fengxian District Bureau of Culture and Tourism, and is jointly organized by Shanghai CHANDO Group, the Dali Craftsman Spirit • Jia Ma Woodblock Print Art Museum, and the Fengxian District Cultural Museum. The exhibition will run through March 1. As part of the broader interregional collaboration framework between Fengxian and Dali, the exhibition offers a platform for cross-regional artistic exchange, tracing a journey from the cultural traditions of the Greater Himalayan region to contemporary printmaking practices along the East China Sea, in line with the exhibition theme "Mountains and Seas in Harmony, Beauty Shared by All." Participants at the exhibition opening Alongside the exhibition, a series of related public programs, including a Spring Festival Garden Fair and a New Year Shopping Festival, are being held. Through a combination of cultural displays, traditional activities, and visitor participation, these programs offer residents and visitors an opportunity to engage with Spring Festival traditions in a contemporary setting. A Cross-Regional Artistic ExchangeSince Fengxian District and Dali Prefecture established a partnership in 2021, the two local governments have worked together on initiatives spanning industrial collaboration, public services, and talent exchange, supported by a multi-level framework for cooperation. This exhibition extends that collaboration into the field of cultural exchange. With operations based in Fengxian and longstanding engagement in Yunnan, CHANDO Group has participated in a range of collaborative initiatives linking the two regions. Dali Prefecture in Yunnan serves as a key source of raw materials for the company. In October 2023, the partners introduced a city-themed co-branded product, the limited-edition Polar Holy Water "Wind, Flower, Snow, Moon" — Dali Edition. In July 2024, additional co-branded products followed, including the euspa "Wind, Flower, Snow, Moon" hair and body care collection and the Dali 3000 Sunscreen Set. In the same year, during the Fengxian–Dali cooperation conference, CHANDO Group donated 500,000 yuan to the Dali Foundation for Poverty Alleviation to support local community initiatives. The joint presentation of this intangible cultural heritage printmaking exhibition reflects a further instance of cultural collaboration between the two regions. At the opening ceremony, Dr. Chen Juanling, General Manager of Public Affairs at CHANDO Group, noted in her remarks that the printmaking exhibition is the 12th initiative in the CHANDO Art Program and coincides with the company's 25th anniversary, under the theme "Together in Beauty." She said the company focuses on bringing together technology, culture, and the natural environment through its public cultural initiatives, and that its participation in the exhibition reflects an ongoing commitment to cultural exchange and to the preservation and contemporary presentation of intangible cultural heritage. She added that the exhibition is intended to show how traditional cultural forms can continue to resonate in contemporary settings, while offering the public a range of participatory experiences, including the garden fair, traditional activities, and interactive programs. Following the remarks, representatives of the participating institutions opened the exhibition and visited CHANDO Future Beauty Innovation Hub, where they viewed both the Science and Art of Cosmetics Exhibition and the Tracing Beauty in Motion printmaking exhibition. Works from both regions are displayed together, fostering dialogue across regions and generations, and highlighting shared cultural appreciation. Intangible Cultural Heritage in Dialogue: A Cross-Regional Exchange between Jia Ma and Fengxian PrintsThe exhibition is organized into two main sections: Marks of Blessing: The Spiritual Map of Jia Ma and Local Dialogues: Fengxian Printmaking Practices, which introduce the artistic traditions and cultural backgrounds of prints from both regions. Dali Jia Ma prints, originating in the Tang Dynasty, are created using traditional woodblock printing techniques on Jia Ma paper. Their motifs feature deities, natural elements, and scenes from daily life, and have traditionally served ritual and ceremonial functions. Historically used in blessing practices, these prints express the Bai community's cultural traditions and social values. Fengxian printmaking, rooted in Jiangnan cultural traditions, draws on established printmaking methods while incorporating contemporary perspectives, using detailed carving and layered compositions to reflect the character of a developing coastal district. Spring Festival Garden Fair and New Year Shopping Festival: Public Cultural Activities and Community EngagementLocated in Fengxian, Shanghai, Oriental Beauty Valley CHANDO Future Beauty Innovation Hub is a flagship project developed by CHANDO Group. The project brings together cultural programming, tourism, retail, and public exhibitions, combining beauty science education, product displays, intelligent manufacturing showcases, and on-site retail, and providing a publicly accessible venue that links industry, education, and cultural experience. It has been recognized as one of Shanghai's Top 10 Iconic Cultural and Tourism Projects for 2025. To coincide with the exhibition opening, CHANDO Future Beauty Innovation Hub launched the Spring Festival Garden Fair and Factory Store New Year Shopping Festival, bringing together traditional culture, hands-on experiences, and consumer activities. The garden fair features public participation stations, including Jia Ma woodblock printing demonstrations, calligraphy and Spring Festival couplets, New Year-themed makeup experiences, seasonal food tastings, fortune drawing, and photo areas, creating a festive environment designed for broad public participation. CHANDO Group introduced the Bai cultural blessing, "Yangyang Hao" to the Shanghai audience, creating a "Good Luck" installation where visitors can record and display New Year wishes, representing shared aspirations for the year ahead. The Factory Store New Year Shopping Festival runs through February 13, offering limited-edition product sets and an additional 10% discount on top of store promotions. By linking cultural programming with commercial activity, the initiative supports seasonal consumer activity while contributing to the coordinated development of cultural, tourism, and commercial offerings. Public Engagement and Regional CooperationCHANDO Group has participated in a range of public-interest and cultural programs, including support for the Keyan Return Program for women in scientific research, the Spring Bud Project for rural education, and initiatives promoting cross-regional cultural exchange. The Group continues to assess ways in which corporate participation can support cultural preservation and regional cooperation. Looking ahead, CHANDO plans to continue utilizing the Oriental Beauty Valley CHANDO Future Beauty Innovation Hub platform to further develop the "cultural, tourism, commercial, and sports exhibitions + industrial tourism" model, with the aim of expanding public access to cultural programs that combine science, art, and everyday life, and supporting sustainable regional cultural development.
Seoul Office Market Enters Structural Reallocation Phase After Record KRW 22.9 Trillion Recovery NEW YORK and SEOUL, Korea, Feb. 3, 2026 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark"), a leading commercial real estate advisor and service provider to global corporations, institutional investors, and owners and occupiers, today released its 2026 Seoul Office Market Outlook for Capital Markets and Leasing, highlighting a robust occupier market alongside a rapidly recovering capital markets environment. Newmark Group, Inc. Executive Commentary "Seoul's office market remains fundamentally resilient across both occupier and capital markets," said John Pritchard, Managing Director and Country Head of Newmark Korea. "We are seeing a strategic reallocation of demand, as corporates and investors focus on higher-quality, more efficient assets. Tenant demand is increasingly concentrating in prime and newly developed offices, while aging stock faces growing competitive pressure." Judy Jang, Executive Director, Head of Research– Korea, added, "Following the record KRW 22.9 trillion transaction year in 2025, capital is returning to the market as confidence in pricing and income stability improves. Looking ahead, asset-level differentiation will be the defining factor for performance, with market polarization becoming a foundational feature of the Seoul office landscape." Occupier Market: Structural Reallocation, Not Demand Exit Corporate relocations across Seoul in 2025 reflect a fundamental shift in workplace strategy rather than cost-driven exits. Major occupiers are consolidating, upgrading and repositioning their office footprints to support hybrid work, collaboration and talent attraction. Tenant decision-making is increasingly driven by building quality, ESG performance, accessibility and workplace experience. As a result, demand continues to concentrate in prime and newly delivered offices, while aging and non-renovated stock faces growing competitive pressure. This mirrors trends observed across global gateway cities such as London, New York, Singapore and Tokyo. Capital Markets: Recovery Turns Fundamental Seoul's office investment market staged a strong recovery in 2025, supported by stabilizing interest rates, improving financing conditions and the return of institutional capital. Core and prime assets in Central Business District (CBD), Gangnam Business District (GBD) and Yeouido Business District (YBD) demonstrated strong downside protection, supported by stable leasing fundamentals and long-term investor conviction. Beyond the traditional core, investor interest is expanding into function-driven office clusters such as Seongsu–Seoul Forest, Magok, Pangyo–Bundang and Sangam DMC, reflecting a broader reallocation of office demand. Supply & Development Cycle Rising construction costs and permitting delays have pushed Seoul's next major supply wave into 2028–2029, extending the current period of limited new completions. Near-term deliveries in 2026, including G1 Seoul, Rene Square and Eul Tower, will test short-term absorption, but pre-leasing momentum suggests that demand for prime assets remains intact. The delayed development pipeline is expected to support rental stability in prime assets while creating a medium-term inflection point for the market cycle. Submarket Outlook CBD: Short-term vacancy volatility driven by large corporate relocations, with asset repositioning accelerating and the major supply cycle delayed to 2028–2029. GBD: Low vacancy due to a limited development pipeline, supported by strong headquarters-driven leasing and owner-occupier demand. YBD: Resilient financial sector demand, portfolio restructuring and redevelopment-driven tenant reshuffling, with future supply largely owner-occupied. Why Seoul Matters to Global Capital Asia's fourth-largest economy Global hub for technology, finance, content, biotech and advanced manufacturing One of Asia's most liquid office investment markets Deep domestic institutional capital base Growing cross-border investor participation About NewmarkNewmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries ("Newmark"), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark's comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform's global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the twelve months ended September 30, 2025, Newmark generated revenues of over $3.1 billion. As of September 30, 2025, Newmark and its business partners together operated from approximately 170 offices with over 8,500 professionals across four continents. To learn more, visit nmrk.com or follow @newmark. Discussion of Forward-Looking Statements about NewmarkStatements in this document regarding Newmark that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company's business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.
TAIPEI, TAIWAN - Media OutReach Newswire - 3 February 2026 - The Asian Smart Medical Online Exhibition 2026 (Medical Asia 2026) is a premier hybrid exhibition designed to seamlessly connect Asian medical suppliers, importers, and exporters with buyers from around the world. Taking place from February 3, 2026, to May 31, 2026, Medical Asia 2026, this four-month online exhibition provides exhibitors with an exceptional platform to showcase their brands, products, and innovations to a truly global audience. Organized by AsianNet and TradeAsia (www.e-tradeasia.com), Medical Asia has been successfully facilitating international medical trade since its launch in 2024 , earning a strong reputation for high-quality participation and tangible business outcomes. In 2026, Medical Asia extends its exhibition period to strategically align with major global healthcare and medical industry events, including Medical Design & Manufacturing West, Arab Health, HIMSS Global Health Conference & Exhibition, MEDICAL JAPAN [Osaka], and Hospitalar Sao Paulo. This extended timeline enables international buyers to engage with multiple key events simultaneously, creating a more efficient and streamlined sourcing experience. By participating in Medical Asia 2026, exhibitors can expect enhanced global exposure, broader networking opportunities, and increased potential for sustainable business growth, all while reaching a larger and more diverse international buyer base through a flexible and cost-effective hybrid exhibition model. Medical Asia 2026 features a robust lineup of respected Taiwanese manufacturers, including industry leaders such as Perfect Medical and many more. These companies will present thousands of the latest smart medical industry products and technologies, covering a wide array of sectors crucial to modern manufacturing and production. The event will feature an extensive selection from top manufacturers, covering categories such as Medical Devices & Clinical Equipment, Medical Supplies & Nursing Consumables, Healthcare Facility Furniture & Logistics Equipment, Emergency & Clinical Patient Monitoring Equipment, Rehabilitation & Physiotherapy Equipment / Consumables, Pharmaceutical Manufacturing, Packaging & Inspection Machinery, Medical-grade Wearables & Remote Patient Monitoring (RPM) Devices, Clinical Laboratory & IVD Analyzers, Medical-grade Materials & Components (Plastics / Rubber / Silicone, etc.), and Home Health Care Products. With thousands of the latest products, accessories, and equipment on display, the exhibition promises to be both comprehensive and highly professional. Attendees will gain valuable insights into the latest innovations and developments across the smart medical industry. Visit the Online Exhibition: https://www.etradeasia.com/online-show/42/Asian-Smart-Medical-Online-Exhibition-2026.html In today's rapidly evolving global environment, online platforms play a crucial role in breaking geographical barriers and extending marketing reach. In response to this growing demand, Medical Asia 2026 offers a comprehensive suite of innovative digital exhibition solutions, including dedicated exhibitor pages, electronic catalogs, and virtual exhibition halls. These digital tools are seamlessly integrated with TradeAsia, enabling international buyers worldwide to effortlessly discover exhibitors and explore products in depth. Through the platform, buyers can visit individual manufacturer pages, review detailed product information, submit inquiries, and communicate with exhibitors via real-time messaging. This highly interactive and user-friendly experience facilitates smooth communication, enhances buyer engagement, and fosters meaningful business connections between exhibitors and global buyers, ultimately creating valuable commercial opportunities. TradeAsia (www.e-tradeasia.com) has been providing comprehensive B2B international trade services for buyers and sellers worldwide since 1997. With nearly three decades of industry experience, TradeAsia is recognized as one of the most established and professional global trade platforms. Today, the platform serves millions of members worldwide, featuring more than 600,000 verified suppliers and millions of up-to-date product listings across diverse industries. Every day, thousands of professional buyers from around the world use TradeAsia to source products, connect with suppliers, and explore new business opportunities. As a leading trade promotion channel in Asia, TradeAsia continues to facilitate efficient cross border trade and foster long term partnerships between global buyers and suppliers. TradeAsia also collaborates with hundreds of trading organizations around the world to exchange marketing and promotional opportunities. As a result, suppliers who showcase their products on TradeAsia gain the chance to be featured across the publicity channels of multiple trade platforms and exhibition organizers worldwide, greatly enhancing their international visibility and marketing reach. In addition, during the period of Medical Asia 2026, promotional messages will be broadcast globally, further amplifying exposure for participating suppliers and connecting them with a wider international audience. Hashtag: #TradeAsia The issuer is solely responsible for the content of this announcement.
SYDNEY, Feb. 3, 2026 /PRNewswire/ -- Miroma Project Factory (MPF) is proud to announce its appointment by Griffith University to co-develop a smart device app designed to support individuals returning home after acquired brain injury (ABI). The project - known as ROBIN: Return Home After Brain Injury - delivers a compassionate, co-designed, and clinically informed digital prototype that supports both patients and care teams through one of the most complex transitions in health: the shift from hospital to home. ROBIN, a smart recovery companion co-created by Miroma Project Factory and Griffith University, bridges the critical transition from rehabilitation to home life. Despite the efforts of rehabilitation services, many people with ABI continue to face unexpected challenges once discharged. Resourcing pressures, fragmented communication, and the overwhelming nature of recovery mean that critical supports often fall away just when patients need them most. That's where ROBIN steps in. A Digital Bridge Between Hospital and Home Built in partnership with the research team from Griffith University and The Hopkins Centre, ROBIN is an AI-enhanced proof-of-concept app that allows people with ABI to track their therapy journey, set meaningful recovery goals, document their experiences, and access support resources - entirely on their own terms. With profile customisation, media-based journaling, and a visual dashboard of progress, it helps users take ownership of their recovery while staying connected to their care network. The app was developed through a co-design approach involving survivors of brain injury, carers, and rehabilitation clinicians to ensure it responds to the real needs and realities of recovery. Each feature - whether it's recording a milestone or mapping life goals - is purpose-built to foster self-awareness, reflection, and a shared understanding of what comes next. "This is about giving people more than just a discharge date. It is about giving them structure, clarity and dignity at a time when those things can feel out of reach. This is at the heart of what Miroma Project Factory does best. Kat Robinson CEO MPF A Launchpad for Innovation in Brain Injury Care Though simple in design, the ROBIN app represents a strategic leap forward in ABI care. As a minimum viable product, it offers a clear and scalable starting point for broader innovation, including future integration with Android devices, real-time data sharing, and wider clinical trials. Early stakeholder feedback confirms its value not just as a patient companion, but as a potential tool for enhancing care coordination and visibility across multidisciplinary teams. MPF's involvement in the project extended beyond UX and technical development. The team worked closely with Griffith University to align the prototype with future research and funding goals - ensuring that ROBIN can evolve into a full-scale digital health intervention, capable of supporting grant applications and informing policy conversations. About ROBIN ROBIN (Return Home After Brain Injury) is a smart device app developed by Griffith University in collaboration with Miroma Project Factory. Created as a MVP (minimum viable product) for research and clinical validation, the app is designed to support individuals transitioning from inpatient rehabilitation to home after an acquired brain injury. ROBIN helps users track progress, set goals, document recovery, and access critical resources in a secure, user-friendly environment. About Miroma Project Factory (MPF) MPF is a multi-award-winning digital strategy and product studio that delivers innovative digital solutions across web, platforms, and systems. Specialising in purposeful technology, MPF works at the intersection of strategy, design, and engineering to create impactful digital products for organisations ready to lead. With deep expertise in healthcare, MPF helps clients scale responsibly, communicate clearly, and connect meaningfully with their audiences. For more information, visit www.theprojectfactory.com. For media enquiries, interviews or partnership opportunities, please contact:Miroma Project Factoryinfo@theprojectfactory.com
New capability enables commercial real estate, AECO, and government teams to remotely assess roof condition, cut inspection costs, and prioritise capital spend across thousands of buildings SYDNEY, Feb. 3, 2026 /PRNewswire/ -- Organisations that manage large building portfolios have long been forced to rely on costly, slow, and inconsistent roof inspections to understand risk and plan maintenance. Today, Nearmap, a global leader in property intelligence, announced the launch of Nearmap Roof Assessment, a new AI-powered capability that allows teams to remotely evaluate roof condition across entire portfolios using high-resolution aerial imagery and automated condition insights. Designed for commercial property owners, AECO firms, and government facility management teams, Roof Assessment replaces fragmented site visits and subjective reports with a centralised, visual system of record for roof health - helping organisations detect issues earlier, prioritise capital investments, and standardise decision-making across distributed assets. "When you can view all the buildings and see and prioritise where you need to spend the money, this is perfect. Instead of having to inspect 150 buildings, we've been able to narrow it down to just 15," said Asset Management and Systems Manager Anu Karunaratne. Built on the accuracy and consistency of Nearmap data, Roof Assessment provides a centralised, visual source of truth that strengthens collaboration between property managers, facility directors, GIS leaders, roof consultants, inspectors, and asset management teams. By reducing unnecessary site visits and equipping teams with objective, shareable roof condition insights, organisations can more confidently plan capital projects, respond to risk, and ensure long-term portfolio resilience. "Too many organisations waste time and money because they're relying on infrequent inspections, inconsistent assessments, or siloed information," said David Tobias, Chief Product Officer at Nearmap. "Roof Assessment gives teams, whether they oversee corporate campuses, government facilities, or complex commercial portfolios, a clear, defensible, and scalable way to understand the health of their roofs. It brings true operational efficiency to asset planning by combining the repeatability of AI with the clarity of high-resolution imagery." Purpose-built for commercial real estate, AECO, and government organisations, Roof Assessment enables reliable, remote monitoring across thousands of sites. Objective condition ratings, high-resolution imagery, and intuitive summaries provide a shared foundation for prioritising inspections, coordinating work, and supporting preventive maintenance strategies. Key benefits include: Evaluate thousands of roofs without sending inspectors onsite, reducing costs, safety risk, and operational disruption Replace subjective reports with standardised, AI-driven condition ratings to support defensible planning and budgeting Give finance, facilities, and external partners the same visual source of truth for faster, more aligned decision-making Detect roof issues earlier to prevent damage and extend asset life through proactive maintenance Improve collaboration and transparency across internal teams, contractors, consultants, and inspectors The introduction of Roof Assessment expands the Nearmap property intelligence offering, reinforcing the company's commitment to help organisations manage risk, optimise capital planning, and make confident, data-driven decisions with an always-current view of the built environment. Nearmap Roof Assessment is available today via MyAccount. For more information, visit: https://www.nearmap.com/au/products/insights/roof-assessment About Nearmap Nearmap is the property intelligence provider customers rely on for consistent, reliable, high-resolution imagery, insights, and answers. Harnessing its own patented camera systems, imagery capture, AI, geospatial tools, and advanced SaaS platforms, Nearmap users receive tailored solutions for complex challenges. Nearmap captures wide-scale urban areas in the United States, Canada, Australia, and New Zealand several times each year, making content instantly available in the cloud via web app or API integration. Founded in Australia in 2007, Nearmap stands as the definitive source of truth that shapes the liveable world. For more information, please visit www.nearmap.com. PR Contact Taylor Cenicola taylor.cenicola@nearmap.com Logo - https://mma.prnasia.com/media2/2741490/Nearmap_Logo.jpg?p=medium600
A12 藝術空間
environment
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
